Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FERG vs GSK✓SelectedUSD · GSKFERG vs GSK performance historyLatest closeAs of+0.62%11/13
Stock and ETF performance explorer

FERG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+424.2%
GSK return
+105.0%
Excess return
+319.3%
Maximum drawdown
-55.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.6%+0.5%+0.1%+0.5%
7D+9.7%+1.1%+8.6%+9.5%
30D+15.0%+6.3%+8.7%+13.7%
3M+3.8%+1.8%+1.9%+3.3%
6M+10.6%+1.7%+9.0%+10.0%
YTD+17.0%+6.5%+10.4%+15.3%
1Y+7.1%+9.5%-2.4%+5.1%
3Y+67.7%+65.3%+2.4%+50.6%
5Y+76.4%+43.7%+32.7%+59.9%
All+424.2%+105.0%+319.3%+365.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling